Essity AB (publ) (ESSITY-A) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Essity AB (publ) (ESSITY-A) has a cash flow conversion efficiency ratio of 0.048x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr4.24 Billion ≈ $456.18 Million USD) by net assets (Skr88.16 Billion ≈ $9.49 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See ESSITY-A equity to assets ratio to measure how much of total assets are equity-financed.
Essity AB (publ) - Cash Flow Conversion Efficiency Trend (2014–2025)
This chart illustrates how Essity AB (publ)'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Essity AB (publ) (ESSITY-A) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Essity AB (publ) Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Essity AB (publ) ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Huntsman Corporation
NYSE:HUN
|
-0.018x |
|
Viridian Therapeutics Inc
NASDAQ:VRDN
|
-0.188x |
|
TX Group AG
SW:TXGN
|
0.039x |
|
Tibet Summit Resources Co Ltd
SHG:600338
|
0.052x |
|
Companhia Siderurgica Nacional ADR
NYSE:SID
|
0.120x |
|
IBI Inv House
TA:IBI
|
0.094x |
|
YY Inc Class A
NASDAQ:YY
|
0.007x |
|
Shenzhen Newway Photomask Making Co. Ltd. A
SHG:688401
|
N/A |
Annual Cash Flow Conversion Efficiency for Essity AB (publ) (2014–2025)
The table below shows the annual cash flow conversion efficiency of Essity AB (publ) from 2014 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Essity AB (publ).
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Skr86.04 Billion ≈ $9.26 Billion |
Skr15.46 Billion ≈ $1.66 Billion |
0.180x | -5.10% |
| 2024-12-31 | Skr88.74 Billion ≈ $9.55 Billion |
Skr16.80 Billion ≈ $1.81 Billion |
0.189x | -30.30% |
| 2023-12-31 | Skr79.41 Billion ≈ $8.55 Billion |
Skr21.57 Billion ≈ $2.32 Billion |
0.272x | +61.54% |
| 2022-12-31 | Skr76.56 Billion ≈ $8.24 Billion |
Skr12.87 Billion ≈ $1.39 Billion |
0.168x | -21.46% |
| 2021-12-31 | Skr68.51 Billion ≈ $7.37 Billion |
Skr14.67 Billion ≈ $1.58 Billion |
0.214x | -23.89% |
| 2020-12-31 | Skr63.34 Billion ≈ $6.82 Billion |
Skr17.82 Billion ≈ $1.92 Billion |
0.281x | -8.70% |
| 2019-12-31 | Skr62.80 Billion ≈ $6.76 Billion |
Skr19.35 Billion ≈ $2.08 Billion |
0.308x | +28.54% |
| 2018-12-31 | Skr54.90 Billion ≈ $5.91 Billion |
Skr13.16 Billion ≈ $1.42 Billion |
0.240x | -6.65% |
| 2017-12-31 | Skr49.57 Billion ≈ $5.33 Billion |
Skr12.73 Billion ≈ $1.37 Billion |
0.257x | -20.46% |
| 2016-12-31 | Skr39.58 Billion ≈ $4.26 Billion |
Skr12.78 Billion ≈ $1.38 Billion |
0.323x | +44.57% |
| 2015-12-31 | Skr48.27 Billion ≈ $5.20 Billion |
Skr10.78 Billion ≈ $1.16 Billion |
0.223x | +2.81% |
| 2014-12-31 | Skr44.92 Billion ≈ $4.83 Billion |
Skr9.76 Billion ≈ $1.05 Billion |
0.217x | -- |
About Essity AB (publ)
Essity AB (publ) develops, produces, and sells hygiene and health products and services in Europe, North and Latin America, Asia, and internationally. The company operates through three segments: Health & Medical, Consumer Goods, and Professional Hygiene. The Health & Medical segment offers incontinence products, wound care, compression therapy, orthopedics, skincare products, and digital solutio… Read more